Anal Fistula Treatment Market Overview 2030
An anal fistula is a small tunnel that connects an abscess, an infected cavity in the anus, to an opening on the skin around the anus. They are usually the result of an infection near the anus, which causes a collection of pus (abscess) in the nearby tissue. Even after the pus drains away, a small channel is left behind. Anal fistulas can cause unpleasant symptoms, such as discomfort, skin irritation, and most of the time they do not get better on their own. Surgery is recommended in most of the cases.
Symptoms include pain, swelling, and discharge of blood or pus from the anus. People may experience pain areas in the rectum, discharge or bleeding from anus, and perianal swelling is also common. An anal fistula usually develops after an anal abscess (a collection of pus) bursts, or when an abscess has not been completely treated. A fistula can even be caused by conditions that affect the intestines, such as inflammatory bowel disease (IBD) or diverticulitis.
COVID-19 Impact Analysis
- COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
- COVID-19 has created an economic crisis in addition to the healthcare crisis. COVID-19 pandemic has stretched healthcare system worldwide; developed countries are expected to cause economic recession. The pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March. Many small hospitals, clinics, and nursing homes, have been forced to shut their operations. In addition, social distancing and localized curfews have resulted in delayed elective surgical procedures. Furthermore, visa cancellations have led to interruption in the medical tourism and have negatively impacted the growth healthcare services market.
- During the COVID-19 crisis, a large amount of workforce has adapted to work from home. Sitting for a long time can be a potential threat for anal fistula, which can lead to growth of the market in upcoming years.
- Anal fistula treatment market is a dynamic industry with significant opportunities for business development but the current COVID-19 conditions caused uncertainty, shifts in short term planning goals, focus on concerns related to near term cost management, and long-term complexity management. Therefore, COVID-19 is expected to have a neutral impact on anal fistula treatment market.
Top Impacting Factors
- Rise in the cases of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis, launch of new products, efforts by market players for the improved technology, growth in the demand for nonsurgical methods such as fibrin glue injection, and adipose-derived stem cells therapy are the key drivers for anal fistula treatment market.
- High cost associated with the procedure such as cost of surgery, the post-operative treatments, and lack of awareness about anal fistula treatment are the market restraints.
- High unmet medical needs in the global anal fistula treatment market presents lucrative opportunities for market players.
Market Trends
A study conducted at the Hospital Santa Izabel, Brazil, published in ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA in 2014, stated that video-assisted fistulotomy proved to be safe and effective in the treatment of anal fistula. This procedure helped directly visualize the internal openings, allowing surgeons to operate without any risk of mistakes. Such technological advancements are projected to augment the anal fistula treatment market.
Increased preference of surgeries for treatment to boost demand in the market
Efforts to ensure good quality of life and low rate of recurrence are expected to drive the demand for surgical treatment. Surgical treatment is highly dependent on the position of fistula. Surgeries are dependent on whether the fistula is branched off or is a single channel. Various surgical procedures comprise seton techniques, advancement flap procedures, bioprosthetic plugs, and fistulotomy. In addition, it comprises new techniques, such as FiLaC therapy, and LIFT therapy. Fistulotomy is the most common type of surgery of anal fistulas.
Key Segments Covered
Key Benefits of Report
- This report presents the detailed analysis of the anal fistula market along with current trends, opportunities and future estimates for the investment in market.
- The report presents information related to the key drivers, restraints, and new technological development in the anal fistula market.
- The current market is analyzed to emphasize the anal fistula treatment market.
- Porter’s five forces analysis illustrate the potency of buyers and suppliers in market.
- The report provides detailed anal fistula treatment market based on market competition and how it is expected to take shape in upcoming years.
Questions Answered in the Anal Fistula Treatment Market Report
- What isanal fistula?
- What are the causes ofanal fistula?
- What are the driving factors, restraints and opportunities of theanal fistula treatmentmarket?
- Which are the leading players in the anal fistula treatmentmarket?
- What future projections will help in taking strategic steps for the future?
- Who are the major end users in the anal fistula treatment market?
- Which is the major regional market inanal fistula treatmentmarket?
- What are the key benefits of this anal fistula treatment market report?
Anal Fistula Treatment Market Report Highlights
| Aspects | Details |
 By Treatment Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Medtronic plc, Takeda Pharmaceuticals, Biolitec AG, W. L. Gore and Associates, Inc., Pfizer Inc., TiGenix NV, Gem srl, Becton, Dickinson and Company, Cook Medical, KARL STORZ SE and Co. KG |
Loading Table Of Content...
